Darrick Carter, PH.D, is the Vice President of Adjuvant Technology at IDRI, a nonprofit global health organization that takes a comprehensive approach in order to combat infectious diseases. IDRI combines the high-quality science of a research organization with the product development capabilities of a biotech company to create new diagnostics, drugs and vaccines. Founded in 1993, IDRI has 125 employees headquartered in Seattle with nearly 100 partners/collaborators around the world. For more information, visit www.idri.org.
Climate change is already suspected of causing legions of deaths every year as a result of extreme weather events: heat waves and floods; degradation of water supplies and sanitation with negative... Read more »